Latest filing: Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR.
ObservedCompany dossier
Bharat Immunologicals
BSE:BIBCL · ISIN INE994B01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bharat Immunologicals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest rating action: Bharat Immunologicals & Biologicals Corporation Limited: Continues to remain under issuer non-cooperating category
Agency sourceMaterial events
Open timeline →What changed recently
Observed
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR.
BSE · exchange filing
Observed
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI'S LODR.
BSE · exchange filing
Observed
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.
BSE · annual report
Observed
Source filing Bharat Immunologicals & Biologicals Corporation Ltd-$ - 524663 - Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015.
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →Awaiting shareholding
No reconciled records in this module yet
A shareholding summary has not been reconciled.